Ovid Therapeutics (OVID) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free OVID Stock Alerts $3.02 +0.02 (+0.67%) (As of 11:42 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineOvid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conferenceglobenewswire.com - May 13 at 7:00 AMReviewing Ovid Therapeutics (NASDAQ:OVID) and Intellipharmaceutics International (OTCMKTS:IPCIF)americanbankingnews.com - May 11 at 1:18 AMOvid Therapeutics Inc. (NASDAQ:OVID) Receives $8.08 Average PT from Brokeragesamericanbankingnews.com - May 10 at 1:14 AMOvid Therapeutics (NASDAQ:OVID) Price Target Cut to $3.50americanbankingnews.com - May 9 at 4:22 AMCracking The Code: Understanding Analyst Reviews For Ovid Therapeuticsmarkets.businessinsider.com - May 7 at 7:18 PMOvid Therapeutics Inc. (NASDAQ:OVID) Receives Consensus Rating of "Moderate Buy" from Analystsmarketbeat.com - May 7 at 4:29 PMOvid Therapeutics (NASDAQ:OVID) PT Lowered to $3.50 at Citigroupmarketbeat.com - May 7 at 2:34 PMOvid Therapeutics Inc. Expected to Earn Q1 2024 Earnings of ($0.26) Per Share (NASDAQ:OVID)americanbankingnews.com - May 3 at 1:42 AMResearch Analysts Offer Predictions for Ovid Therapeutics Inc.'s Q1 2024 Earnings (NASDAQ:OVID)marketbeat.com - May 2 at 7:33 AMFFT Wealth Management LLC Invests $1.27 Million in Ovid Therapeutics Inc. (NASDAQ:OVID)marketbeat.com - May 1 at 8:04 PMHC Wainwright Weighs in on Ovid Therapeutics Inc.'s Q1 2024 Earnings (NASDAQ:OVID)marketbeat.com - May 1 at 7:50 AMHC Wainwright & Co. Initiates Coverage of Ovid Therapeutics (OVID) with Buy Recommendationnasdaq.com - April 30 at 9:40 AMOvid Therapeutics (NASDAQ:OVID) Now Covered by Analysts at B. Rileymarketbeat.com - April 30 at 8:35 AMWe Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growthfinance.yahoo.com - April 18 at 9:24 AMOvid Therapeutics Inc. (NASDAQ:OVID) Short Interest Down 23.7% in Marchmarketbeat.com - April 13 at 4:57 PMOvid Therapeutics gains on bullish view at Wedbushmsn.com - April 5 at 6:25 PMOvid Therapeutics (NASDAQ:OVID) Coverage Initiated at Wedbushmarketbeat.com - April 5 at 8:21 AMOvid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 4 at 8:00 AMMarinus Pharmaceuticals Stands Firm in Patent Dispute Over Key Epilepsy Treatmentmsn.com - April 2 at 8:07 AMMarinus Pharmaceuticals' patent battle with New York firm over seizure therapy takes new twistbizjournals.com - March 29 at 5:22 PMOvid therapeutics CEO acquires $50k in company stockinvesting.com - March 22 at 7:33 PMOvid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buyingfinance.yahoo.com - March 22 at 8:51 AMOvid Therapeutics Inc. (NASDAQ:OVID) CEO Jeremy M. Levin Acquires 18,248 Sharesinsidertrades.com - March 21 at 10:32 AMJeremy M. Levin Purchases 18,248 Shares of Ovid Therapeutics Inc. (NASDAQ:OVID) Stockmarketbeat.com - March 20 at 7:54 PM5 Oversold Biotech Stocks To Buy Right Nowinsidermonkey.com - March 17 at 7:29 PMOvid Therapeutics: Strong Buy Rating on Robust Pipeline and Strategic Partnershipsmarkets.businessinsider.com - March 13 at 7:49 AMOvid gas station, state and local officials dealing with contaminated fuel problemnews.yahoo.com - March 13 at 1:54 AMOvid gas station shut down after discovery of water inside pumpsmsn.com - March 13 at 1:54 AMTD Cowen Sticks to Its Buy Rating for Ovid Therapeutics (OVID)markets.businessinsider.com - March 11 at 8:32 AMOVID Oct 2024 7.500 callfinance.yahoo.com - March 9 at 7:17 AMRecap: Ovid Therapeutics Q4 Earningsbenzinga.com - March 8 at 10:42 AMOvid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 8 at 8:00 AMOvid Therapeutics Inc (OVID)investing.com - March 7 at 11:47 PMOvid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conferenceglobenewswire.com - February 28 at 8:00 AMOvid-Elsie girls win third straight conference titlenews.yahoo.com - February 22 at 9:16 AMOvid Therapeutics Inc. (NASDAQ:OVID) Short Interest Updatemarketbeat.com - February 17 at 8:11 AMOVID Mar 2024 5.000 callfinance.yahoo.com - February 17 at 1:37 AMOVID Apr 2024 5.000 callfinance.yahoo.com - February 17 at 1:37 AMTaysha transfers rights to 3 programs, extends cash runway into 2026msn.com - February 15 at 6:49 PMOvid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 8:46 AMCirculatory cholesterol levels are inversely linked to mortality of patients with sepsis and critical illnessmsn.com - February 1 at 1:24 PMOwning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc. (NASDAQ:OVID),finance.yahoo.com - January 18 at 8:28 AMOvid Therapeutics Inc. (NASDAQ:OVID) Sees Large Increase in Short Interestmarketbeat.com - January 14 at 5:06 PMBTIG Keeps Their Buy Rating on Ovid Therapeutics (OVID)markets.businessinsider.com - January 3 at 9:45 AMEnavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitorsfinance.yahoo.com - January 2 at 8:45 AMOvid Therapeutics Stock (NASDAQ:OVID), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 22 at 2:13 PMOvid Therapeutics Stock (NASDAQ:OVID) Dividends: History, Yield and Datesbenzinga.com - December 21 at 6:56 PMBTIG Initiates Coverage of Ovid Therapeutics (OVID) with Buy Recommendationmsn.com - December 21 at 6:56 PMOvid Therapeutics (NASDAQ:OVID) Earns Buy Rating from Analysts at BTIG Researchmarketbeat.com - December 21 at 7:16 AMS&W Seed Company Appoints Jeffrey Rona to Its Board of Directorsfinance.yahoo.com - December 19 at 9:35 AM Get Ovid Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OVID and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s Next Move Will Disrupt AI Forever (Ad)A revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100. Get all the information here. OVID Media Mentions By Week OVID Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OVID News Sentiment▼0.170.58▲Average Medical News Sentiment OVID News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OVID Articles This Week▼81▲OVID Articles Average Week Get Ovid Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for OVID and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATOS News GBIO News OMER News RENB News RIGL News GALT News MACK News TRVI News GTHX News LFCR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OVID) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorNext President (Not Trump. Not Biden.)The Freeport SocietyThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovid Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
